Cost-effectiveness analysis of a system-based approach for managing neonatal jaundice and preventing kernicterus in Ontario

被引:8
作者
Xie, Bin [1 ]
da Silva, Orlando [1 ]
Zaric, Greg [1 ]
机构
[1] Univ Western Ontario, London, ON N6A 4G5, Canada
关键词
Comparative effectiveness research; Jaundice; Kernicterus; Neonatology; CEREBRAL-PALSY; NEAR-TERM; HYPERBILIRUBINEMIA; MANAGEMENT; BILIRUBIN; INFANTS; STRATEGIES; DISCHARGE; NEWBORNS; CANADA;
D O I
10.1093/pch/17.1.11
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE: To evaluate the incremental cost-effectiveness of a system-based approach for the management of neonatal jaundice and the prevention of kernicterus in term and late-preterm (>= 35 weeks) infants, compared with the traditional practice based on visual inspection and selected bilirubin testing. STUDY DESIGN: Two hypothetical cohorts of 150,000 term and late-preterm neonates were used to compare the costs and outcomes associated with the use of a system-based or traditional practice approach. Data for the evaluation were obtained from the case costing centre at a large teaching hospital in Ontario, supplemented by data from the literature. RESULTS: The per child cost for the system-based approach cohort was $176, compared with $173 in the traditional practice cohort. The higher cost associated with the system-based cohort reflects increased costs for predischarge screening and treatment and increased postdischarge follow-up visits. These costs are partially offset by reduced costs from fewer emergency room visits, hospital readmissions and kernicterus cases. Compared with the traditional approach, the cost to prevent one kernicterus case using the system-based approach was $570,496, the cost per life year gained was $26,279, and the cost per quality-adjusted life year gained was $65,698. CONCLUSION: The cost to prevent one kernicterus case using the system-based approach is much lower than previously reported in the literature.
引用
收藏
页码:15 / 20
页数:6
相关论文
共 50 条
  • [41] Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients
    Blank, Patricia R.
    Filipits, Martin
    Dubsky, Peter
    Gutzwiller, Florian
    Lux, Michael P.
    Brase, Jan C.
    Weber, Karsten E.
    Rudas, Margaretha
    Greil, Richard
    Loibl, Sibylle
    Szucs, Thomas D.
    Kronenwett, Ralf
    Schwenkglenks, Matthias
    Gnant, Michael
    PHARMACOECONOMICS, 2015, 33 (02) : 179 - 190
  • [42] Efficient diagnosis and treatment of acute paracetamol poisoning: cost-effectiveness analysis of approaches based on a hospital toxicovigilance program
    Munoz Romo, Raul
    Borobia Perez, Alberto M.
    Munoz, Mario A.
    Carballo Cardona, Cesar
    Cobo Mora, Julio
    Carcas Sansuan, Antonio J.
    EMERGENCIAS, 2018, 30 (03): : 169 - 176
  • [43] Cost-Effectiveness of Mobile Health-Based Integrated Care for Atrial Fibrillation: Model Development and Data Analysis
    Luo, Xueyan
    Xu, Wei
    Ming, Wai-Kit
    Jiang, Xinchan
    Yuan, Quan
    Lai, Han
    Huang, Chunji
    Zhong, Xiaoni
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (04)
  • [44] Cost-effectiveness analysis of gene-based therapies for patients with spinal muscular atrophy type I in Australia
    Wang, Tianjiao
    Scuffham, Paul
    Byrnes, Joshua
    Downes, Martin
    JOURNAL OF NEUROLOGY, 2022, 269 (12) : 6544 - 6554
  • [45] Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective
    Borba, Helena H. L.
    Rochau, Ursula
    Wiens, Astrid
    Sroczynski, Gaby
    Siebert, Uwe
    Ferreira, Vinicius L.
    Minowa, Eimy
    Pontarolo, Roberto
    VALUE IN HEALTH REGIONAL ISSUES, 2019, 20 : 95 - 102
  • [46] Active Surveillance and Decolonization of Methicillin-Resistant Staphylococcus aureus on Admission to Neonatal Intensive Care Units in Hong Kong: A Cost-Effectiveness Analysis
    You, Joyce H. S.
    Chan, C. Y.
    Wong, M. Y.
    Ip, Margaret
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2012, 33 (10) : 1024 - 1030
  • [47] Cost-effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model-based analysis
    Portnoy, Allison
    Pedersen, Kine
    Sy, Stephen
    Trope, Ameli
    Engesaeter, Birgit
    Kim, Jane J.
    Burger, Emily A.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (06) : 1073 - 1081
  • [48] Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis
    Hamers, Raph L.
    Sawyer, A. W.
    Tuohy, Martin
    Stevens, Wendy S.
    de Wit, Tobias F. Rinke
    Hill, Andrew M.
    AIDS, 2012, 26 (13) : 1663 - 1672
  • [49] A China-Based Cost-Effectiveness Analysis of Novel Oral Anticoagulants versus Warfarin in Patients with Left Ventricular Thrombosis
    Tian, Shuo
    Zhong, Haitao
    Yin, Mengyue
    Jiang, Pei
    Liu, Qiao
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2024, 17 : 945 - 953
  • [50] The Diagnosis of Malignant Pleural Effusion Using Tumor-Marker Combinations: A Cost-Effectiveness Analysis Based on a Stacking Model
    Wang, Jingyuan
    Zhou, Jiangjie
    Wu, Hanyu
    Chen, Yangyu
    Liang, Baosheng
    DIAGNOSTICS, 2023, 13 (19)